Mingqiang Li
Papers
2
Total Citations
26
H-Index
2
About
Mingqiang Li is a pioneering researcher at the intersection of nanotechnology, biomedical engineering, and intelligent sensing. His work spans two transformative domains: advanced CRISPR-based nanotheranostics for tackling viral hepatitis and hepatocellular carcinoma, and next-generation triboelectric acoustic sensors for human-machine collaboration. In his highly cited 2025 study, Li developed a deep learning-enhanced anti-noise triboelectric acoustic sensor that achieves robust voice recognition in noisy environments—a breakthrough with profound implications for health monitoring, post-disaster rescue, and intelligent control systems. This work has already garnered 24 citations, reflecting its immediate impact. Earlier, Li contributed to a landmark review in *Advanced Science* (2021) on CRISPR nanotheranostics, envisioning nanoscale CRISPR/Cas systems as "smart enzymatic robots" for precision therapy against liver diseases. His interdisciplinary approach—merging nanomaterials, gene editing, and artificial intelligence—positions him as a leading voice in creating intelligent, theranostic platforms. With a growing citation record and cutting-edge innovations, Li’s research is shaping the future of smart biomedical devices and human-machine interfaces.
Research Focus
Key Achievements
Top Papers
- 1
- 2